• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Association of Patient Characteristics, Diabetes, BMI, and Obesity With Severe COVID-19 in Metropolitan Detroit, MI.密歇根州底特律市患者特征、糖尿病、体重指数和肥胖与重症 COVID-19 的关联
Clin Diabetes. 2022 Spring;40(2):141-152. doi: 10.2337/cd21-0065. Epub 2022 Apr 15.
2
Hospitalization and Mortality among Black Patients and White Patients with Covid-19.新冠病毒感染住院患者的病死率:黑人和白人患者的比较。
N Engl J Med. 2020 Jun 25;382(26):2534-2543. doi: 10.1056/NEJMsa2011686. Epub 2020 May 27.
3
Clinical Characteristics and Morbidity Associated With Coronavirus Disease 2019 in a Series of Patients in Metropolitan Detroit.在底特律市区的一系列患者中,与 2019 年冠状病毒病相关的临床特征和发病率。
JAMA Netw Open. 2020 Jun 1;3(6):e2012270. doi: 10.1001/jamanetworkopen.2020.12270.
4
Sex Disparity in the Effect of Obesity in Hospitalized COVID-19 Patients: A Retrospective Cohort Study From the New York City Metropolitan Area.肥胖对住院COVID-19患者影响中的性别差异:一项来自纽约市大都市区的回顾性队列研究。
Cureus. 2021 May 25;13(5):e15235. doi: 10.7759/cureus.15235.
5
The Impact of Sociodemographic Factors, Comorbidities, and Physiologic Responses on 30-Day Mortality in Coronavirus Disease 2019 (COVID-19) Patients in Metropolitan Detroit.大都市底特律 2019 年冠状病毒病(COVID-19)患者的社会人口因素、合并症和生理反应对 30 天死亡率的影响。
Clin Infect Dis. 2021 Jun 1;72(11):e704-e710. doi: 10.1093/cid/ciaa1420.
6
Association of Body Mass Index and Age With Morbidity and Mortality in Patients Hospitalized With COVID-19: Results From the American Heart Association COVID-19 Cardiovascular Disease Registry.体重指数和年龄与 COVID-19 住院患者发病率和死亡率的关系:美国心脏协会 COVID-19 心血管疾病登记研究结果。
Circulation. 2021 Jan 12;143(2):135-144. doi: 10.1161/CIRCULATIONAHA.120.051936. Epub 2020 Nov 17.
7
Obesity and Mortality Among Patients Diagnosed With COVID-19: Results From an Integrated Health Care Organization.肥胖与新冠肺炎确诊患者的死亡率:来自一体化医疗保健组织的研究结果。
Ann Intern Med. 2020 Nov 17;173(10):773-781. doi: 10.7326/M20-3742. Epub 2020 Aug 12.
8
Elevated glycohemoglobin is linked to critical illness in CoVID-19: a retrospective analysis.糖化血红蛋白升高与新型冠状病毒肺炎危重症相关:一项回顾性分析
Ther Adv Infect Dis. 2021 Jun 25;8:20499361211027390. doi: 10.1177/20499361211027390. eCollection 2021 Jan-Dec.
9
Clinical Characteristics and Risk Factors for Mortality in Critical COVID-19 Patients Aged 50 Years or Younger During Omicron Wave in Korea: Comparison With Patients Older Than 50 Years of Age.韩国奥密克戎变异株流行期间 50 岁及以下危重症 COVID-19 患者的临床特征及死亡危险因素:与 50 岁以上患者的比较。
J Korean Med Sci. 2023 Jul 17;38(28):e217. doi: 10.3346/jkms.2023.38.e217.
10
How Do Presenting Symptoms and Outcomes Differ by Race/Ethnicity Among Hospitalized Patients With Coronavirus Disease 2019 Infection? Experience in Massachusetts.在因感染 2019 冠状病毒病而住院的患者中,不同种族/族裔的临床表现和结局有何不同?马萨诸塞州的经验。
Clin Infect Dis. 2021 Dec 6;73(11):e4131-e4138. doi: 10.1093/cid/ciaa1245.

引用本文的文献

1
Severity of SARS-CoV-2 Illness in Patients With Type 1 and Type 2 Diabetes Mellitus.1型和2型糖尿病患者感染新型冠状病毒2型的疾病严重程度
HCA Healthc J Med. 2025 Apr 1;6(2):119-129. doi: 10.36518/2689-0216.1824. eCollection 2025.
2
Venous thrombosis and obesity: from clinical needs to therapeutic challenges.静脉血栓形成与肥胖:从临床需求到治疗挑战
Intern Emerg Med. 2025 Jan;20(1):47-64. doi: 10.1007/s11739-024-03765-7. Epub 2024 Sep 13.
3
The Impact of Comorbidities among Ethnic Minorities on COVID-19 Severity and Mortality in Canada and the USA: A Scoping Review.加拿大和美国少数族裔合并症对 COVID-19 严重程度和死亡率的影响:一项范围综述。
Infect Dis Rep. 2024 Apr 23;16(3):407-422. doi: 10.3390/idr16030030.
4
Obesity, Inflammation, and Clinical Outcomes in COVID-19: A Multicenter Prospective Cohort Study.肥胖、炎症与 COVID-19 临床结局:一项多中心前瞻性队列研究。
J Clin Endocrinol Metab. 2024 Oct 15;109(11):2745-2753. doi: 10.1210/clinem/dgae273.
5
COVID-19 vaccine coverage, safety, and perceptions among patients with diabetes mellitus in China: a cross-sectional study.中国糖尿病患者的 COVID-19 疫苗接种率、安全性和认知情况:一项横断面研究。
Front Endocrinol (Lausanne). 2023 Jun 1;14:1172089. doi: 10.3389/fendo.2023.1172089. eCollection 2023.

本文引用的文献

1
Association of body mass index with severity and mortality of COVID-19 pneumonia: a two-center, retrospective cohort study from Wuhan, China.体重指数与新型冠状病毒肺炎严重程度及死亡率的关联:一项来自中国武汉的双中心回顾性队列研究。
Aging (Albany NY). 2021 Mar 24;13(6):7767-7780. doi: 10.18632/aging.202813.
2
Impact of undiagnosed type 2 diabetes and pre-diabetes on severity and mortality for SARS-CoV-2 infection.未诊断的 2 型糖尿病和糖尿病前期对严重程度和 SARS-CoV-2 感染死亡率的影响。
BMJ Open Diabetes Res Care. 2021 Feb;9(1). doi: 10.1136/bmjdrc-2020-002026.
3
Inflammatory markers are poorly predictive of clinical outcomes among hospitalized patients with COVID-19.在因 COVID-19 住院的患者中,炎症标志物对临床结局的预测效果不佳。
Am J Emerg Med. 2021 Aug;46:595-598. doi: 10.1016/j.ajem.2020.11.038. Epub 2020 Nov 24.
4
Obesity is associated with increased severity of disease in COVID-19 pneumonia: a systematic review and meta-analysis.肥胖与 COVID-19 肺炎疾病严重程度增加相关:系统评价和荟萃分析。
Eur J Med Res. 2020 Dec 2;25(1):64. doi: 10.1186/s40001-020-00464-9.
5
Racial and Ethnic Disparities in COVID-19-Related Infections, Hospitalizations, and Deaths : A Systematic Review.COVID-19 相关感染、住院和死亡的种族和民族差异:系统评价。
Ann Intern Med. 2021 Mar;174(3):362-373. doi: 10.7326/M20-6306. Epub 2020 Dec 1.
6
Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: A systematic review and meta-analysis.2019冠状病毒病的血栓栓塞风险很高,且与更高的死亡风险相关:一项系统评价和荟萃分析。
EClinicalMedicine. 2020 Dec;29:100639. doi: 10.1016/j.eclinm.2020.100639. Epub 2020 Nov 20.
7
Retrospective cohort study of clinical characteristics of 2199 hospitalised patients with COVID-19 in New York City.对纽约市2199名住院的新冠肺炎患者临床特征的回顾性队列研究。
BMJ Open. 2020 Nov 27;10(11):e040736. doi: 10.1136/bmjopen-2020-040736.
8
Obesity Management in Primary Care During and Beyond the COVID-19 Pandemic.新冠疫情期间及之后基层医疗中的肥胖管理
J Nurse Pract. 2021 Apr;17(4):428-431. doi: 10.1016/j.nurpra.2020.11.007. Epub 2020 Nov 14.
9
Ethnicity and clinical outcomes in COVID-19: A systematic review and meta-analysis.COVID-19中的种族与临床结局:一项系统评价与荟萃分析。
EClinicalMedicine. 2020 Dec;29:100630. doi: 10.1016/j.eclinm.2020.100630. Epub 2020 Nov 12.
10
BMI as a Risk Factor for Clinical Outcomes in Patients Hospitalized with COVID-19 in New York.BMI 作为纽约因 COVID-19 住院患者临床结局的危险因素。
Obesity (Silver Spring). 2021 Feb;29(2):279-284. doi: 10.1002/oby.23076. Epub 2020 Dec 23.

密歇根州底特律市患者特征、糖尿病、体重指数和肥胖与重症 COVID-19 的关联

Association of Patient Characteristics, Diabetes, BMI, and Obesity With Severe COVID-19 in Metropolitan Detroit, MI.

作者信息

Hehar Jaspreet, Todter Erika, Lahiri Sharon W

机构信息

Department of Internal Medicine, Division of Endocrinology, Diabetes, Bone and Mineral Disorders, Henry Ford Health System, Detroit, MI.

Department of Public Health Sciences, Henry Ford Health System, Detroit, MI.

出版信息

Clin Diabetes. 2022 Spring;40(2):141-152. doi: 10.2337/cd21-0065. Epub 2022 Apr 15.

DOI:10.2337/cd21-0065
PMID:35669303
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9160544/
Abstract

Identification of specific risk factors for severe coronavirus disease 2019 (COVID-19) is crucial for prevention of poor outcomes and mortality. This retrospective cohort study of patients hospitalized with COVID-19 demonstrated that older age, male sex, Black race, diabetes, elevated BMI, and elevated inflammatory markers were correlated with critical illness in COVID-19. Older age, male sex, diabetes, and inflammatory markers, but not elevated BMI, were associated with mortality. Despite having greater odds of critical illness, Black patients had lower odds of death than White patients. Older age, male sex, diabetes, and elevated inflammatory markers were significantly associated with venous thromboembolism. These findings suggest a need to aggressively identify and manage modifiable risk factors (i.e., diabetes and elevated BMI) and encourage vaccination of at-risk individuals to prevent poor outcomes from COVID-19.

摘要

确定2019冠状病毒病(COVID-19)重症的特定风险因素对于预防不良结局和死亡至关重要。这项针对COVID-19住院患者的回顾性队列研究表明,高龄、男性、黑人种族、糖尿病、BMI升高和炎症标志物升高与COVID-19危重症相关。高龄、男性、糖尿病和炎症标志物与死亡率相关,但BMI升高与死亡率无关。尽管黑人患者患危重症的几率更高,但与白人患者相比,其死亡几率更低。高龄、男性、糖尿病和炎症标志物升高与静脉血栓栓塞显著相关。这些发现表明,有必要积极识别和管理可改变的风险因素(即糖尿病和BMI升高),并鼓励高危人群接种疫苗,以预防COVID-19的不良结局。